E. Ploumen

发表

Coronary bifurcations treated with thin-strut drug-eluting stents: a prespecified analysis of the randomized BIO-RESORT trial.

C. von Birgelen, G. Linssen, C. Schotborgh, 2021, Coronary artery disease.

New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials.

M. Stoel, A. Roguin, C. von Birgelen, 2020, American heart journal.

Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS

G. De Luca, C. von Birgelen, Elvin Kedhi, 2020, Cardiovascular Diabetology.

Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials

M. Stoel, A. Roguin, C. von Birgelen, 2020, International Journal of Cardiology.

Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial

A. Roguin, C. von Birgelen, G. Linssen, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Novel DES aims at full thromboresistance: Another promising player on the field?

C. von Birgelen, E. Ploumen, E. H. Ploumen, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms

Shao-Liang Chen, G. Helft, C. von Birgelen, 2022, Journal of personalized medicine.

Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials.

M. Stoel, A. Roguin, C. von Birgelen, 2022, Atherosclerosis.

First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial.

A. Roguin, C. von Birgelen, C. Schotborgh, 2021, Circulation journal : official journal of the Japanese Circulation Society.

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial

M. Stoel, F. H. Man, C. von Birgelen, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study

M. Stoel, C. von Birgelen, G. Linssen, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years.

M. Stoel, A. Roguin, C. von Birgelen, 2020, JACC. Cardiovascular interventions.

Thin, Very Thin, or Ultrathin Strut Biodegradable- or Durable-Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT.

M. Stoel, C. von Birgelen, G. Linssen, 2019, JACC. Cardiovascular interventions.

Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease.

M. Stoel, A. Roguin, C. von Birgelen, 2022, International journal of cardiology.

Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers

M. Stoel, C. von Birgelen, G. Linssen, 2022, Journal of the American Heart Association.

Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials

A. Roguin, C. von Birgelen, C. Schotborgh, 2021, Cardiovascular Diabetology.

Use of the left radial artery as vascular access for coronary angiography and as a bypass conduit: A clinical dilemma?

C. von Birgelen, J. V. Van Til, F. Halfwerk, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Drug-eluting stents for ST-segment elevation myocardial infarction: extending the biodegradable versus durable polymer debate

E. Ploumen, R. Buiten, 2023, The Lancet.

Coronary bifurcations treated with thin-strut drug-eluting stents: a prespecified analysis of the randomized comparison of biodegradable polymer and durable polymer drug-eluting stents in an all comers population trial.

C. von Birgelen, G. Linssen, C. Schotborgh, 2020, Coronary artery disease.

First myocardial infarction in patients with premature coronary artery disease: insights into patient characteristics and outcome after treatment with contemporary stents

A. Roguin, C. von Birgelen, G. Linssen, 2023, European heart journal. Acute cardiovascular care.

Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention

C. von Birgelen, G. Linssen, C. Schotborgh, 2023, Frontiers in cardiovascular medicine.

Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial.

C. von Birgelen, G. Linssen, C. Schotborgh, 2019, JAMA cardiology.

Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease.

M. Stoel, C. von Birgelen, G. Linssen, 2024, Atherosclerosis.

Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.

R. Kornowski, C. von Birgelen, G. Musumeci, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.